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Background: Balloon angioplasty (BA) is an alternative to surgical repair for coarcta-
tion of the aorta (CoA) in children. However, its role in the treatment of native CoA 
in neonates and infants remains controversial. The purpose of this study was to report 
the midterm outcomes of BA for native CoA in neonates and infants with congestive 
heart failure (CHF).
Methods: Between July 2000 and March 2007, 18 neonates and infants with native 
CoA and CHF who underwent BA were enrolled. Patients without recoarctation were 
designated as group A, while those with recoarctation or CHF were designated as 
group B. The clinical presentations, laboratory data, and outcomes were compared 
between groups.
Results: There were 10 patients in group A and eight in group B. The mean age was 
2.8 ± 3.1 months (range, 0.7−11 months). Mean body weight was 4.0 ± 1.9 kg (range, 
2.1−8.0 kg). CHF improved markedly in all patients immediately after BA, with a 
reduction in systolic pressure gradient from 36.4 ± 12.0 to 5.6 ± 6.0 mmHg (p < 0.001). 
The recoarctation rate was 44% (8/18). The risk factors for restenosis were post-BA 
systolic pressure gradient > 10 mmHg (p = 0.007) and CoA diameter < 3 mm (p = 0.013).
Conclusions: The outcomes of BA for native CoA in neonates and infants with CHF 
remain poor. The incidence of recoarctation is high in neonates and patients whose 
post-BA systolic pressure gradient is  > 10 mmHg or whose CoA diameter is < 3 mm.
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1. Introduction
In 1983, Lababidi performed the first balloon angio-
plasty (BA) for coarctation of the aorta (CoA).1 BA 
has been reported to be an effective treatment for 
recurrent CoA after surgery in children.2 Despite
its acceptable morbidity and low complication 
rates, the utility of BA for native CoA in neonates 
and infants remains controversial, because of its 
higher restenosis rate, increased risk of aneurysm 
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formation, and potential limb ischemia.3,4 However, 
these patients frequently present with congestive 
heart failure (CHF), which might also increase the 
surgical risk. Thus, BA may be a less invasive and 
safer alternative to surgery in this particular popu-
lation group. The purpose of this study was to re-
port the midterm outcomes of BA for native CoA in 
neonates and infants with CHF.
2. Materials and Methods
Between July 2000 and March 2007, 18 neonates 
and infants with native, discrete CoA and CHF who 
underwent BA were enrolled. Informed consent 
was obtained from the parents. The retrieval of the 
patients’ medical records was approved by the in-
stitutional review board of our institution. Exclusion 
criteria included previous aortic surgery, associ-
ated significant aortic arch or isthmus hypoplasia, 
or other complex anomalies such as hypoplastic 
left heart syndrome, transposition of the great ar-
teries, or univentricular heart. All but three patients 
with large ventricular septal defects (VSD) or pat-
ent ductus arteriosus (PDA) associated with pulmo-
nary hypertension (mean pressure > 40 mmHg) were 
referred for surgery.
Transcatheter treatment was performed using 
standard techniques, as described previously.5 All 
procedures were performed under local anesthesia 
with intravenous ketamine (1 mg/kg/dose) for seda-
tion. All patients received prophylactic antibiotic 
treatment with one dose of intravenous cefazolin 
(25 mg/kg). Intravenous heparin (100 U/kg) was 
administered during the intervention. A 4- or 5-Fr 
right coronary catheter was passed into the descend-
ing aorta, and the pressure distal to the CoA was 
measured. The catheter was then advanced across 
the CoA with the aid of a 0.025” Terumo guidewire 
(Terumo Medical Corp., Tokyo, Japan) and the pres-
sure in the ascending aorta was recorded. Aortograms 
were obtained from the lateral plane and 15° left 
or right of the anterior oblique projection. The di-
ameter of the CoA, isthmus just above the CoA, 
and the descending aorta to the level of the dia-
phragm were measured simultaneously. A balloon 
with a diameter ≤ 1 mm less than that of the isthmus, 
or not exceeding the diameter of the descending 
aorta, was used. After careful positioning, 3−6 in-
flations of the balloon catheter were made using 
dilute contrast (1:4) with short inflation times (< 15 
seconds). If there was no significant change in the 
lesion or the systolic pressure gradient across the 
CoA was still > 20 mmHg, the next size larger bal-
loon was used. Aspirin (3−5 mg/kg/day) was admin-
istered for 6 months after the procedure. Technical 
success was defined as an immediate reduction in 
peak systolic pressure gradient across the CoA to 
< 20 mmHg.
During follow-up, patients without recoarctation 
were designated as group A, while those with reco-
arctation or CHF were designated as group B. 
Recoarctation was defined as a systolic pressure 
gradient > 20 mmHg across the CoA segment. Blood 
pressure measurement of the upper and lower limbs 
was performed every month for the first 6 months, 
and every 3−6 months thereafter, during follow-up. 
Blood pressure of upper limb > lower limb was indic-
ative of suspected recoarctation. Echocardiography 
was performed at 3 and 6 months post-BA, and then 
once annually. Peak velocity > 2.5 m/s across the 
previous CoA was considered indicative of resteno-
sis. Cardiac catheterization with angiography was 
performed in our first five cases and in patients 
with suspected recoarctation based on abnormal 
blood pressure data or Doppler findings. Surgery was 
considered if restenosis was confirmed by aortog-
raphy or chest computed tomography. The clinical 
presentations, laboratory data, and outcomes were 
compared between groups.
2.1. Statistical analysis
The data were expressed as mean ± standard devia-
tion. Comparison of parameters between the groups 
was performed with Student’s t-test and Fisher’s 
exact test, as appropriate. Statistical analysis
was per formed using the “Statistics Package” for 
Social Sciences 9.0 for Windows (SPSS, Chicago, IL, 
USA). A p value < 0.05 was considered statistically 
significant.
3. Results
The study population consisted of 15 boys and 3 
girls. There were 10 patients in group A and eight 
patients in group B. The mean age was 2.8 ± 3.1 
months (range, 0.7−11 months) and the mean weight 
was 4.0 ± 1.9 kg (range, 2.1−8.0 kg). There were 10 
neonates (age < 1 month) and eight infants. Technical 
success was noted in all 18 cases. The mean peak-
to-peak systolic pressure gradient across the CoA 
decreased from 36.4 ± 12.0 mmHg to 5.6 ± 6.0 mmHg 
(p < 0.001) after angioplasty. CHF completely re-
solved or markedly improved immediately after BA 
in all patients. The demographic and clinical data 
are summarized in Table 1. The recoarctation rate 
was 44% (8/18). The risk factors for recoarctation are 
shown in Table 2. There were no statistically signifi-
cant differences between group A and group B in 
terms of age (p = 0.064), body weight (p = 0.421), 
gender (p = 0.559), associated PDA (p = 0.321), pre-
BA systolic pressure gradient (p = 0.059), mean 
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pulmonary artery pressure (p = 0.351), or follow-up 
period (p = 0.774). The risk factors for restenosis 
were post-BA systolic pressure gradient > 10 mmHg 
(p = 0.007) and CoA diameter < 3 mm (p = 0.013).
Associated cardiac defects were present in 15 
(83%) of these patients and included PDA (n = 6), VSD 
(n = 6), atrial septal defect (ASD) (n = 11), mitral reg-
urgitation (n = 1) and right aortic arch with aber-
rant left subclavian artery (n = 1). In addition, nine of 
the 18 patients had pulmonary hypertension (mean 
pressure > 25 mmHg) before BA. Mean pulmonary ar-
tery pressure was 28 ± 16 mmHg (range, 12−61 mmHg). 
Among the patients with these associated anomalies, 
one patient underwent coil implantation of PDA 
during the same procedure (Figure 1). Delayed sur-
gical intervention, performed in four patients, in-
cluded VSD + ASD (n = 1), VSD + PDA (n = 1), VSD + 
ASD + PDA (n = 1) and ASD (n = 1). Nine patients had 
spontaneous closure of ASD, VSD, PDA or stable he-
modynamic status without further treatment. 
Three patients had associated non-cardiac abnor-
malities, including Poland syndrome, seizure disor-
der, and cerebral palsy (n = 1 each).
In group B, one patient had recoarctation and 
asymptomatic innominate artery occlusion.6 The in-
nominate artery occlusion was due to malpositioning 
Table 1  Baseline clinical characteristics of coarctation of the aorta in neonates and infants with congestive
heart failure
 Age (m) Sex BW (kg) PGB PGA D (mm) MPAP AA F/U (m) Outcome
1 1 M 2.7 51 14 1.5 16 A + V 95 RS
2 8 M 7.6 22 7 3.2 29 (−) 101 Good
3 5 F 8.0 23 8 2.5 12 P 89 RS
4 0.5 M 3.6 35 4 4.0 31 (−) 10 Good
5 1 M 2.6 52 19 3.0 16 (−) 59 RS
6 7 M 5.3 34 0 2.0 28 A 63 Good
7 1 M 3.0 30 0 2.0 26 A + V 25 Good
8 1 M 2.1 50 12 1.5 18 A + P 20 RS
9 4 M 5.5 39 7 4.0 45 A + P + V 90 Good
10 11 M 4.7 21 2 3.5 12 A 88 Good
11 0.3 M 3.0 33 0 2.9 61 A + P 67 RS
12 6 F 6.5 29 6 5.1 18 MA 54 Good
13 1 M 3.3 40 0 1.8 69 V + P 36 Good
14 2 M 5.5 52 11 2.5 20 A + V 12 RS
15 0.7 M 2.2 43 0 2.0 18 A 32 Good
16 0.7 M 3.0 56 0 2.8 20 A 17 RS
17 0.7 F 2.5 25 10 2.5 30 P 10 RS
18 1.7 M 2.5 20 0 3.5 39 A + V 10 Good
A = atrial septal defect; AA = associated anomaly; BW = body weight; D = diameter; F/U = follow-up; MA = mitral regurgitation 
and arch anomaly; MPAP = mean pulmonary artery pressure; P = patent ductus arteriosus; PGB = pressure gradient before balloon 
angioplasty; PGA = pressure gradient after balloon angioplasty; RS = restenosis; V = ventricular septal defect.
Table 2 Comparison of risk factors for recoarctation in neonates and infants with congestive heart failure
 Group A (n = 10) Group B (n = 8) p value
Age (months) 4.1 ± 3.7 1.5 ± 1.5 0.064
Weight (kg) 4.4 ± 1.8 3.7 ± 2.0 0.421
PGB (mmHg) 31.3 ± 8.3 42.8  ± 13.4 0.059
PGA (mmHg) 2.6 ± 3.1 10.6 ± 7.3 0.012*
MPAP (mmHg) 31.5 ± 16.5 24.1 ± 15.8 0.351
CoA diameter (mm) 3.1 ± 1.1 2.4 ± 0.6 0.125
Follow-up (months) 50.9 ± 33.6 46.1 ± 35.5 0.774
PGA ≥ 10 mmHg 0/10 5/8 0.007*
Sex (M/F) 9/1 6/2 0.559
Associated PDA 2/10 4/8 0.321
CoA diameter ≤ 3 mm 4/10 8/8 0.013*
Age ≤ 1 month 4/10 6/8 0.188
*Significant was defined as p < 0.05. CoA = coarctation of the aorta; MPAP = mean pulmonary artery pressure; PDA = patent ductus 
arteriosus; PGB = pressure gradient before balloon angioplasty; PGA = pressure gradient after balloon angioplasty.
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of the balloon catheter during BA. Surgical repair 
of the recurrent CoA was subsequently undertaken. 
Due to the lack of symptoms related to the oc-
cluded right innominate artery, there was no fur-
ther intervention of the vessel. Asymptomatic right 
femoral artery occlusion occurred in one patient, 
and one aneurysm formation in the aorta was found 
by computed tomography (Figure 2). No other com-
plications were found in group A patients.
In group B, eight patients had restenosis during 
follow-up. Three patients had restenosis 1 month 
after BA, one patient at 3 months, three patients at 
4 months and one patient at 15 months. Five of 
them were discovered by routine blood pressure 
measurement and three by echocardiography. Only 
one patient had mild CHF during follow-up. The 
other seven patients were asymptomatic. Seven of 
eight patients underwent subsequent elective sur-
gery. The parents of the remaining patient refused 
any further treatment.
4. Discussion
CoA is a common congenital aortic anomaly. During 
the newborn period, CoA accounts for 7% of pa-
tients presenting with cardiac lesions, and is de-
tected at autopsy in 17% of newborns that die of 
congenital heart disease.7
CoA may be associated with congenital cardiac 
anomalies such as PDA, VSD, tricuspid atresia, mitral 
atresia, atrioventricular septal defect, hypoplastic 
A B
Figure 1 (A) Aortography shows a discrete coarctation (arrow) and patent ductus arteriosus in a 4-month-old infant. 
(B) Six years after balloon angioplasty of coarctation and coil embolization of arterial duct, the aorta remains patent 
without restenosis.
A B
Figure 2 (A) Left ventriculography demonstrates coarctation of the aorta in a 21-day-old neonate. (B) Nine months 
after balloon angioplasty, computed tomography demonstrates recoarctation (arrow) and a small aortic aneurysm proxi-
mal to the CoA narrowest part (arrow head).
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left heart syndrome, transposition of the great ar-
teries, and double outlet right and left ventricle. 
Among these anomalies, PDA and VSD are the most 
common.8 CoA is especially frequent in patients 
with Turner’s syndrome, with an incidence of 12%.9 
None of the patients in the current study had 
Turner’s syndrome.
The clinical manifestations of CoA vary. CHF is 
the most common finding in neonates and infants. 
In contrast, the majority of older children and ad-
olescents with CoA are asymptomatic, and such 
patients are usually disclosed following hyperten-
sion survey or by the presence of heart murmurs. CoA 
is generally a slowly progressive lesion; with time 
and growth, the obstruction tends to become more 
severe and the collateral circulation more exten-
sive. At our midterm follow-up, restenosis occurred 
in seven patients within 4 months after BA, five of 
which were discovered by routine blood pressure 
measurement. Because most patients are asymp-
tomatic, routine blood pressure measurement is 
important, especially within 4 months after BA.
With the improvement in balloon techniques and 
surgical interventions, the natural course of CoA is 
now unknown. However, past experience suggests 
that unrepaired CoA might lead to death at a younger 
age,10 a greater tendency to develop atheroscle-
rotic disease, myocardial infarction, and cerebral 
vascular accidents,11 spontaneous rupture and dis-
section of the aorta,12 or rupture of berry aneu-
rysms.13 Heart failure was previously the most 
common cause of death, followed by bacterial en-
darteritis and intracranial hemorrhage.14
The results of the VACA (Valvuloplasty and Angio-
plasty of Congenital Anomalies) registry confirm 
that native CoA can be effectively dilated.4 Early 
restenosis is an important issue, however, especially 
in neonates, and when severe isthmus and trans-
verse arch hypoplasia coexist. In infants with CHF, 
however, the procedure may have a palliative role, 
where short-term benefit may be anticipated to 
provide metabolic and hemodynamic relief, allowing 
elective surgical repair to be performed at a later 
age.15,16 In cases of association with other cardiac 
anomalies, improvement of CHF may allow stabili-
zation of the patient pending more definite treat-
ment. Although eight patients in this study eventually 
required surgical repair, BA immediately improved 
these patients’ heart failure status and thus allowed 
elective surgery, making the results more favorable.
The mechanism of restenosis may be associated 
with multiple factors, including ductal tissue con-
striction or recoil, isthmus hypoplasia, intimal hyper-
plasia, and matrix protein production with arterial 
remodeling.17,18 The younger the age, the narrower 
the aortic isthmus, and the smaller the coarctated 
segment (both before and after angioplasty), and the 
greater the chance of recoarctation.19 In general, 
the recoarctation rate was higher in neonates than 
in infants. Recoarctation was reported in 71−83% 
of neonates after BA.20,21 In our study, neonates 
had a higher rate of restenosis than infants (75% vs. 
25%). However, there was no statistical significance 
(p = 0.188). Association with PDA was also considered 
to be a risk factor for recoarctation.17 In our study, 
CoA associated with PDA had a higher incidence of 
restenosis (50% vs. 20%), but there was no statisti-
cally significant difference (p = 0.321). However, this 
could be related to the small sample size in our study. 
Analysis of the results revealed that a small caliber 
of coarctated aortic segments < 3 mm (p = 0.013) and 
higher post-BA systolic pressure gradient > 10 mmHg 
(p = 0.007) were risk factors for restenosis.
Intimal and medial damage is necessary for suc-
cessful BA, and aortic aneurysm is a potential com-
plication. Rao et al reported that 5% of infants and 
children who underwent angioplasty had developed 
aneurysms at a mean follow-up of 14 months.21 In 
our study, one patient had an aortic aneurysm dur-
ing the follow-up period and the incidence of an-
eurysm was therefore 5.6%. In Fiore et al’s study, 
three of 23 patients had aneurysm formation.22 All 
three patients received a second angioplasty. Aortic 
aneurysm formation was highly associated with re-
peat angioplasty and unsuccessful BA in native 
CoA. Second BA for native CoA may therefore not 
be appropriate, and elective surgical repair for re-
current CoA was advocated in our patients.
Fiore et al compared BA and surgery for neonatal 
CoA.22 In their study, the BA group had a higher 
rate of recoarctation and required more antihy-
pertensive medication compared with the surgery 
group (57% vs.18% and 33% vs. 7%, respectively). 
However, comparisons between the two treatment 
modalities were problematic, because neonatal 
CoA had wide morphologic variability, including prox-
imal tubular isthmus, distal aortic arch hypoplasia, 
and associated intracardiac defects, and the study 
was retrospective and nonrandomized. Fletcher et al 
and Fiore et al found that BA for native CoA was 
effective in older children.22,23 However, BA is less 
satisfactory than surgery in young infants and ne-
onates with CoA, because of its higher restenosis 
rate. Nevertheless, BA still has the advantage of 
relieving CHF immediately after the procedure.
5. Conclusions
The outcome of BA for native CoA in neonates and 
infants with CHF remains poor. The incidence of re-
coarctation is high in neonates and patients whose 
post-BA systolic pressure gradient is > 10 mmHg or 
whose CoA diameter is < 3 mm.
Balloon angioplasty for coarctation of the aorta 157
References
1. Lababidi Z. Neonatal transluminal balloon coarctation angio-
plasty. Am Heart J 1983;106:752−3.
2. Witsenburg M, The SH, Bogers AJ, Hess J. Balloon angio-
plasty for aortic recoarctation in children: initial and fol-
low up results and midterm effect on blood pressure.
Br Heart J 1993;70:170−4.
3. Rao PS, Chopra PS, Koscik R, Smith PA, Wilson AD. Surgical 
versus balloon therapy for aortic coarctation in infants ≤ 3 
months old. J Am Coll Cardiol 1994;23:1479−83.
4. Tynan M, Finley JP, Fontes V, Hess J, Kan J. Balloon angio-
plasty for the treatment of native coarctation: results of 
valvuloplasty and angioplasty of congenital anomalies reg-
istry. Am J Cardiol 1990;65:790−2.
5. Beekman RH, Rocchine AP, Dick M 2nd, et al. Percutaneous 
balloon angioplasty for native coarctation of the aorta.
J Am Coll Cardiol 1987;10:1078−84.
6. Ko SF, Liang CD, Huang CC, et al. Clinical feasibility of free-
breathing, gadolinium-enhanced magnetic resonance angi-
ography for assessing extracardiac thoracic vascular 
abnormalities in young children with congenital heart dis-
eases. J Thorac Cardiovasc Surg 2006;132:1092−8.
7. Izukawa T, Mulholland HC, Rowe RD, et al. Structural heart 
disease in the newborn. Changing profile-comparison of 1975 
with 1965. Arch Dis Child 1979;54:281−5.
8. Anderson RH, Lenox CC, Zuberbuhler JR. Morphology of ven-
tricular septal defect associated with coarctation of aorta. 
Br Heart J 1983;50:176−81.
9. Ho VB, Bakalov VK, Cooley M, et al. Major vascular anomalies 
in Turner syndrome: prevalence and magnetic resonance 
angiographic features. Circulation 2004;110:1694−700.
10. Campbell M. Natural history of coarctation of the aorta.
Br Heart J 1970;32:633−40.
11. Liberthson RR, Pennington DG, Jacobs ML, Daggett WM. 
Coarctation of the aorta: review of 234 patients and clarifica-
tion of management problems. Am J Cardiol 1979;43:835−40.
12. Strauss RG, McAdams AJ. Dissecting aneurysm in childhood. 
J Pediatr 1970;76:578−84.
13. Glancy DL, Morrow AG, Simon AL, Roberts WC. Juxtaductal 
aortic coarctation: analysis of 84 patients studied hemody-
namically, angiographically, and morphologically after age 
1 year. Am J Cardiol 1983;51:537−51.
14. Baylis JH, Campbell M. The course and prognosis of coarc-
tation of the aorta. Br Heart J 1956;18:475−95.
15. Morrow WR, Vick GW 3rd, Nihill MR, et al. Balloon dilatation 
of unoperated coarctation of the aorta: short- and
intermediate-term results. J Am Coll Cardiol 1988;11:133−8.
16. Suarez de Lezo J, Pan M, Romero M, et al. Percutaneous 
interventions on severe coarctation of the aorta: a 21-year 
experience. Pediatr Cardiol 2005;26:176−89.
17. Ino T, Ohkubo M. Dilation mechanism, causes of restenosis 
and stenting in balloon coarctation angioplasty. Acta Pediatr 
1997;86:367−71.
18. Beekman RH, Rocchini AP, Behrendt DM, et al. Long-term 
outcome after repair of coarctation in infancy: subclavian 
angioplasty does not reduce the need for reoperation.
J Am Coll Cardiol 1986;8:1406−11.
19. Rao PS, Koscik R. Validation of risk factors in predicting 
recoarctation after initially successful balloon angioplasty 
for native aortic coarctation. Am Heart J 1995;130:116−21.
20. Redington AN, Booth P, Shore DF, Rigby ML. Primary balloon 
dilatation of coarctation of the aorta in neonates. Br Heart J 
1990;64:277−81.
21. Rao PS, Galal O, Smith PA, Wilson AD. Five- to nine-year 
follow-up results of balloon angioplasty of native aortic coarc-
tation in infants and children. J Am Coll Cardiol 1996;27:
462−70.
22. Fiore AC, Fisher LK, Schwartz T, et al. Comparison of angio-
plasty and surgery for neonatal aortic coarctation. Ann 
Thorac Surg 2005;80:1659−64.
23. Fletcher SE, Nihill MR, Grifka RG, et al. Balloon angioplasty 
of native coarctation of the aorta: midterm follow-up and 
prognostic factors. J Am Coll Cardiol 1995;25:730−4.
